Skip to main content
. 2016 Dec 7;13(2):266–270. doi: 10.1080/21645515.2017.1264755

Figure 3.

Figure 3.

EBOV GP-specific antibody responses to different orders of prime and boost administration, with 14-, 28- and 56-day prime- boost interval (EBL1001 study data, shown up to 21 d post-boost), assessed by ELISA (enzyme-linked immunosorbent assay). GMC, geometric mean concentration; GP: glycoprotein.